Current status on the therapeutic strategies for heart failure and diabetic cardiomyopathy

Area of Science:

• Cardiology
• Endocrinology
• Diabetology

Background:

• Heart failure (HF) is a major cause of cardiovascular death, with high mortality rates.
• Type 2 diabetes mellitus (T2DM) significantly increases the risk of developing HF.
• Global prevalence of both diabetes and HF continues to rise, necessitating updated management strategies.

Purpose of the Study:

• To provide an overview of current heart failure (HF) management.
• To discuss treatments for both heart failure with reduced ejection fraction (HFrEF) and heart failure with preserved ejection fraction (HFpEF).
• To explore the relationship between HF, T2DM, and diabetic cardiomyopathy, including therapeutic approaches.

Main Methods:

• This is a review article.
• Literature search on current HF guidelines and T2DM comorbidities.
• Synthesis of information on HF subtypes and diabetes-related cardiac complications.

Main Results:

• Heart failure remains a critical condition with significant mortality.
• T2DM is a major risk factor for HF development and progression.
• Emerging therapeutic strategies address both HF and T2DM concurrently.

Conclusions:

• Updated treatment protocols for HFrEF and HFpEF are crucial.
• Understanding the interplay between T2DM and HF is vital for effective patient care.
• Integrated therapeutic approaches are needed for patients with comorbid HF and diabetes.